Cargando…
Can mild cognitive impairment and Alzheimer’s disease be diagnosed by monitoring a miRNA triad in the blood?
Objectively diagnosing age‐related cognitive impairment (ACI), mild cognitive impairment (MCI), and early‐stage Alzheimer's disease (AD) is a difficult task, as most cognitive impairment is clinically established via questionnaires, history, and physical examinations. A recent study has suggest...
Autores principales: | Wei, Zhuang‐Yao D., Shetty, Ashok K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197398/ https://www.ncbi.nlm.nih.gov/pubmed/35537095 http://dx.doi.org/10.1111/acel.13627 |
Ejemplares similares
-
Separation of cognitive domains to improve prediction of progression from mild cognitive impairment to Alzheimer's disease
por: Hendrix, Suzanne B, et al.
Publicado: (2013) -
Sex-specific hippocampal connectivity markers in mild cognitive impairment
por: Yang, Yuan, et al.
Publicado: (2023) -
Differential Expression and miRNA–Gene Interactions in Early and Late Mild Cognitive Impairment
por: Brito, Leonardo Miranda, et al.
Publicado: (2020) -
Neuroinflammation in mild respiratory COVID-19: insights into cognitive impairment in milder cases
por: Li, Qian, et al.
Publicado: (2022) -
Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer's Dementia
por: Adler, Georg, et al.
Publicado: (2018)